PhaseRx, Inc.
PZRX
PZRX was delisted on the 2nd of February, 2018.
7 hedge funds and large institutions have $237K invested in PhaseRx, Inc. in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
17% more funds holding
Funds holding: 6 → 7 (+1)
10% less capital invested
Capital invested by funds: $263K → $237K (-$26K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$57.3K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$39.1K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$6.75K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1.42K |
| 5 |
Morgan Stanley
New York
|
+$94 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$50.4K |
PZRX Hedge Fund Activity: Q3 2017 in Review
7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in PhaseRx, Inc. (PZRX) for Q3 2017, worth a combined $237K — down 9.9% from $263K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new PZRX positions and 1 closed out — a net gain of 2 holders — while 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $57.3K. The largest seller was Vanguard Group, cutting an estimated $50.4K.
- 7 institutional investors held PhaseRx, Inc. (PZRX) as of Q3 2017, up from 6 in Q2 2017.
- Funds reported $237K of PhaseRx, Inc. stock for Q3 2017, down 9.9% quarter-over-quarter.
- 3 funds opened new PhaseRx, Inc. positions in Q3 2017 and 1 closed out, a net change of +2 holders.
- The largest PhaseRx, Inc. buyer in Q3 2017 was Virtu Financial, an estimated $57.3K added.
- The largest PhaseRx, Inc. seller in Q3 2017 was Vanguard Group, an estimated $50.4K sold.
Based on aggregated 13F filings for Q3 2017.